Chemotherapy

CHEMOTHERAPY 6 SERIES 3-WEEK CYCLE OF TAC REGIMENT Taxotere, Adriamycin & Cyclophosphamide DAY ONE 6 HOURS OF TREATMENT DAY TWO NEULASTA INJECTIONS DAYS THREE, FOUR, & FIVE TWO WEEKS 1of6 DAILY FLUIDS AND ANTI- NAUSEA MEDICATION GIVEN INTRAVENOUSLY VIRTUALLY NO SIDE EFFECTS Continualy inoreasing erergy levels DAYS SIX & SEVEN O OLERAE COMPLETION Approximately 5 months of treatment total CHEMOTHERAPY SIDE EFFECTS SCALE Thegoe sty of ng e pantandgton g pn bud and oty THE WILL TO SURVIVE The National Cancer Institute estimates SURVIVAL RATE INCREASE that approximately 13-7 million Americans with a history of cancer were ALIVE on 68% equivalent to the prevention of 1.18 MILLION cancer survivors January 1, 2012. 49% It is estimated that by January 1, 2022, the population of cancer survivors will increase to almost 18 million ở 8.8 million males O 9.2 million females 20% The number of people who will survive a cancer diagnosis is expected to increase by 31% over the next ten years. DEATH-RATE DECREASE 1975-1977 2002-2008